Trials / Completed
CompletedNCT03403283
Dyslipidemia and Diabetic Retinopathy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 45 (actual)
- Sponsor
- University of Alabama at Birmingham · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine if the reparative cells of blood vessels called endothelial progenitor cells(EPC) are defective in people with diabetes.
Detailed description
The purpose of this study is to determine if the reparative cells of blood vessels, called endothelial progenitor cells (EPC's) are defective in people with diabetes. Diabetic retinopathy (DR) is an eye disease related to diabetes. It can cause blurred vision and possible bleeding in the blood vessels in the back of the eye (retina). Damage to the cells of the blood vessels from DR can cause vision loss or blindness. Even with current treatments, the quality of life for people with DR is much reduced.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | 15 subjects with Non Proliferative Diabetic Retinopathy(mild, moderate and severe). 15 subjects with Proliferative Diabetic Retinopathy | |
| OTHER | Healthy Controls 15 age matched control subjects |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2023-04-30
- Completion
- 2023-04-30
- First posted
- 2018-01-18
- Last updated
- 2024-05-21
- Results posted
- 2024-05-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03403283. Inclusion in this directory is not an endorsement.